cbdMD to acquire Twinlab brands and operating assets
cbdMD reached a definitive asset purchase agreement to acquire Twinlab operating assets and brands via an assignment for the benefit of creditors process.
Portfolio includes Twinlab, Reserveage, Metabolife and Alvita Tea, expanding into legacy supplements, sports nutrition, beauty, weight loss and longevity.
Combined unaudited trailing 12-month revenue through June 2026 is estimated at about $30 million, roughly 40% above cbdMD standalone.
The deal aims to reduce reliance on hemp-derived products, broadening the company into a multi-brand consumer wellness platform.
Closing remains subject to court approval and customary closing conditions.
YCBD•
